feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
IDL Biotech: Opportunity at a discount
Research Update
2019-04-25
07:30
We provide a short research update with the latest financial estimates and valuation following IDL Biotech’s Q1’19 report
LS
Ludvig Svensson
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans